Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

A woman with severe hair loss was successfully treated with the drug adalimumab.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Abatacept may help some people with alopecia areata regrow hair.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.